Analyst Coverage Initiated: DSGN rating Outperform by Wedbush
Price Target: $21
Report Date: 06-10-2022
Symbol: DSGN - Design Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Analyst Coverage Initiated: DSGN rating Outperform by Wedbush
Price Target: $21
Design Therapeutics, Inc. (DSGN)
6005 Hidden Valley Road
Carlsbad, CA 92011
Phone: 858 293 4900
Website: https://www.designtx.com
CEO:
NASDAQ, Nasdaq Global Select
Design Therapeutics, Inc. develops therapies for the treatment of degenerative disorders caused by nucleotide repeat expansions. The company engages in the development of a program for the treatment of Friedreich's ataxia and degenerative diseases such as Fragile X syndrome and myotonic dystrophy. The company was incorporated in 2017 and is based in Carlsbad, California.
stock market signals, daily stock signals, best trading signals, free stock signals
Good stock signals have been found on this server. That is all we know.
+1 (407) 559-7228